ATA38277A - Verfahren zur herstellung eines attenuierten panleukopenie-virus bzw. eines dieses attenuierte virus enthaltenden impfstoffes - Google Patents

Verfahren zur herstellung eines attenuierten panleukopenie-virus bzw. eines dieses attenuierte virus enthaltenden impfstoffes

Info

Publication number
ATA38277A
ATA38277A AT77382A AT38277A ATA38277A AT A38277 A ATA38277 A AT A38277A AT 77382 A AT77382 A AT 77382A AT 38277 A AT38277 A AT 38277A AT A38277 A ATA38277 A AT A38277A
Authority
AT
Austria
Prior art keywords
attenuated
virus
producing
vaccine containing
panleukopenia
Prior art date
Application number
AT77382A
Other languages
English (en)
Other versions
AT360147B (de
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of ATA38277A publication Critical patent/ATA38277A/de
Application granted granted Critical
Publication of AT360147B publication Critical patent/AT360147B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14311Parvovirus, e.g. minute virus of mice
    • C12N2750/14322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Flanged Joints, Insulating Joints, And Other Joints (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT38277A 1976-01-23 1977-01-21 Verfahren zur herstellung eines attenuierten panleukopenie-virus bzw. eines dieses attenuierte virus enthaltenden impfstoffes AT360147B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2602478A DE2602478C3 (de) 1976-01-23 1976-01-23 Impfstoff gegen die Panleukopenie der Feliden

Publications (2)

Publication Number Publication Date
ATA38277A true ATA38277A (de) 1980-05-15
AT360147B AT360147B (de) 1980-12-29

Family

ID=5968104

Family Applications (1)

Application Number Title Priority Date Filing Date
AT38277A AT360147B (de) 1976-01-23 1977-01-21 Verfahren zur herstellung eines attenuierten panleukopenie-virus bzw. eines dieses attenuierte virus enthaltenden impfstoffes

Country Status (17)

Country Link
US (1) US4312947A (de)
AT (1) AT360147B (de)
BE (1) BE850696A (de)
CH (1) CH629962A5 (de)
DE (1) DE2602478C3 (de)
DK (1) DK147033C (de)
ES (2) ES455137A1 (de)
FI (1) FI60408C (de)
FR (1) FR2338708A1 (de)
GB (1) GB1576223A (de)
IE (1) IE44691B1 (de)
IT (1) IT1076012B (de)
LU (1) LU76616A1 (de)
NL (1) NL7700482A (de)
NO (2) NO152936C (de)
PT (1) PT66097B (de)
SE (1) SE426550B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2702634A1 (de) * 1977-01-22 1978-07-27 Behringwerke Ag Verfahren zur herstellung einer vaccine gegen die panleukopenie der katze
ATE1070T1 (de) * 1978-11-30 1982-06-15 The Wellcome Foundation Limited Abgeschwaechter stamm des bei feliden infektioese peritonitis verursachenden virus, verfahren zu seiner herstellung und ihn enthaltender impfstoff.
US4193990A (en) * 1979-02-16 1980-03-18 Cornell Research Foundation, Inc. Heterotypic canine parvovirus vaccine
US4711778A (en) * 1980-07-30 1987-12-08 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL300960A (de) * 1962-11-27
GB1177635A (en) * 1966-02-18 1970-01-14 Wellcome Found Cell Stains.
US3892627A (en) * 1973-06-04 1975-07-01 Rohm & Haas Feline panleukopenia vaccine

Also Published As

Publication number Publication date
BE850696A (fr) 1977-07-25
IT1076012B (it) 1985-04-22
ES455137A1 (es) 1977-12-16
IE44691L (en) 1977-07-23
DK24977A (da) 1977-07-24
SE426550B (sv) 1983-01-31
NO152937C (no) 1985-12-18
FI60408B (fi) 1981-09-30
AT360147B (de) 1980-12-29
NO770208L (no) 1977-07-26
NO152936C (no) 1985-12-18
PT66097B (de) 1978-08-03
DE2602478A1 (de) 1977-07-28
DE2602478B2 (de) 1980-01-31
FI60408C (fi) 1982-01-11
GB1576223A (en) 1980-10-01
SE7700652L (sv) 1977-07-24
NO152937B (no) 1985-09-09
IE44691B1 (en) 1982-02-24
DK147033C (da) 1984-09-03
FR2338708A1 (fr) 1977-08-19
DE2602478C3 (de) 1980-10-09
NO772101L (no) 1977-07-26
LU76616A1 (de) 1977-07-27
CH629962A5 (de) 1982-05-28
FR2338708B1 (de) 1980-03-28
US4312947A (en) 1982-01-26
NO152936B (no) 1985-09-09
FI770181A (de) 1977-07-24
ES458954A1 (es) 1978-07-16
PT66097A (de) 1977-02-01
NL7700482A (nl) 1977-07-26
DK147033B (da) 1984-03-26

Similar Documents

Publication Publication Date Title
ATA304479A (de) Verfahren zur herstellung eines oxidkomplexkatalysators
AT355947B (de) Verfahren zur herstellung eines oxydischen schleifmittels
AT364853B (de) Verfahren zur herstellung eines mono- oder disalzes des n-phosphonomethylglycins
AT336637B (de) Verfahren zur herstellung von n-phosphonomethylglycin
AT363178B (de) Verfahren zur herstellung einer stabilen wasser -in-oel-emulsion fuer die zubereitung von adjuvanspraeparaten fuer impfstoffe bzw. von impfstoffen
DD132231A5 (de) Verfahren zur herstellung einer emulsion von perfluorkohlenstoffverbindungen
DD131762A5 (de) Verfahren zur herstellung eines pferde-rhinopneumonievakzins
AT344925B (de) Verfahren zur herstellung eines alkali- oder ammoniuminsulins
AT360147B (de) Verfahren zur herstellung eines attenuierten panleukopenie-virus bzw. eines dieses attenuierte virus enthaltenden impfstoffes
AT373613B (de) Verfahren zur herstellung von polysiloxanen
ATA268678A (de) Verfahren zur herstellung eines isomalto-oligo- saccaridgemisches
AT354835B (de) Verfahren zur herstellung eines zusatzfutter- mittels
AT363978B (de) Verfahren zur herstellung von elektromagnetischen, kornorientierten siliciumstaehlen
AT357020B (de) Verfahren zur herstellung verstaerkter wellpappe
ATE4638T1 (de) Verfahren zur herstellung eines insulins.
AT358821B (de) Kontinuierliches verfahren zur herstellung eines saeuremittels
AT363979B (de) Verfahren zur herstellung eines elektromagnetischen siliciumstahls
AT361453B (de) Verfahren zur herstellung von sekundaeren aliphatischen aminen bzw. aetheraminen
AT347223B (de) Verfahren zur herstellung eines futter bzw. nahrungsmittels
AT351160B (de) Verfahren zur herstellung einer abgeschwaechten influenzavirusvakzine
DD134446A1 (de) Verfahren zur herstellung eines einkomponentenepoxidharzsystems
AT355738B (de) Verfahren zur herstellung eines optisch aktiven aldehyd-zwischenproduktes
AT357174B (de) Verfahren zur herstellung eines asbestdia- phragmas
DD136617A1 (de) Verfahren zur herstellung konzentrierter latices durch aufrahmung
AT363453B (de) Verfahren zur herstellung von ammoniumalkanoaten

Legal Events

Date Code Title Description
ELA Expired due to lapse of time
REN Ceased due to non-payment of the annual fee